SERM closely related to tamoxifen — used for PCT and gyno control.
Typical dose range: 30–120 mg
Frequency: Daily
Route: Oral
Half-life: ~5 days
Evidence level: Approved (oncology)
Often considered a smoother alternative to tamoxifen with a friendlier lipid profile.